Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 1/2011

01-01-2011 | Original Paper

Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy

Authors: Peter J. Psaltis, Angelo Carbone, Darryl P. Leong, Dennis H. Lau, Adam J. Nelson, Tim Kuchel, Troy Jantzen, Jim Manavis, Kerry Williams, Prashanthan Sanders, Stan Gronthos, Andrew C. W. Zannettino, Stephen G. Worthley

Published in: The International Journal of Cardiovascular Imaging | Issue 1/2011

Login to get access

Abstract

Cardiac fibrosis plays an important prognostic role in nonischemic cardiomyopathy (NICM), making it a potential therapeutic target. Although electromechanical mapping has been used to identify myocardial scar and facilitate intramyocardial intervention in the setting of ischemic heart disease, its application has not been described in NICM. We assessed the detection of myocardial fibrosis by endoventricular electromechanical mapping in an experimental model of NICM. The NOGA® XP system was used to perform left ventricular mapping in twelve sheep that had undergone intracoronary doxorubicin dosing to induce NICM and in six healthy control animals. Results for endocardial voltage and mechanical shortening were evaluated against myocardial fibrosis burden, as determined by delayed-enhancement cardiac magnetic resonance and quantitative histomorphometry. Doxorubicin treatment resulted in dilated cardiomyopathy with moderate-severe impairment of left ventricular ejection fraction. Late gadolinium uptake was present in 9/12 doxorubicin animals, while histological fibrosis was approximately doubled compared to controls and was distributed multisegmentally throughout the left ventricle. Cardiomyopathy was associated with widespread reductions in unipolar and bipolar voltage amplitude and endocardial shortening. Each parameter showed an inverse relationship with the burden of fibrosis. Moreover, unipolar voltage and linear local shortening ratio displayed moderate accuracy for identifying myocardial segments with delayed contrast enhancement or increased fibrosis content, with optimal discriminatory thresholds of 7.5 mV and 11.5%, respectively. In this model of NICM, electromechanical mapping shows potential for delineating segmental differences in fibrosis. Pending clinical evaluation, it may therefore have applicability for directing targeted intramyocardial interventions in nonischemic heart disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Felker GM, Thompson RE, Hare JM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084CrossRefPubMed Felker GM, Thompson RE, Hare JM et al (2000) Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342:1077–1084CrossRefPubMed
2.
go back to reference Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985CrossRefPubMed Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985CrossRefPubMed
3.
go back to reference Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414–2421CrossRefPubMed Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414–2421CrossRefPubMed
4.
go back to reference Psaltis PJ, Gronthos S, Worthley SG, Zannettino ACW (2008) Cellular therapy for cardiovascular disease part 2—delivery of cells and clinical experience. Clin Med Cardiol 2:139–151 Psaltis PJ, Gronthos S, Worthley SG, Zannettino ACW (2008) Cellular therapy for cardiovascular disease part 2—delivery of cells and clinical experience. Clin Med Cardiol 2:139–151
5.
go back to reference Seth S, Narang R, Bhargava B et al (2006) Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 48:2350–2351CrossRefPubMed Seth S, Narang R, Bhargava B et al (2006) Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 48:2350–2351CrossRefPubMed
6.
go back to reference Fischer-Rasokat U, Assmus B, Seeger FH et al (2009) A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2:417–423CrossRefPubMed Fischer-Rasokat U, Assmus B, Seeger FH et al (2009) A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circ Heart Fail 2:417–423CrossRefPubMed
7.
go back to reference Freyman T, Polin G, Osman H et al (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114–1122CrossRefPubMed Freyman T, Polin G, Osman H et al (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114–1122CrossRefPubMed
8.
go back to reference Perin EC, Silva GV, Assad JA et al (2008) Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 44:486–495CrossRefPubMed Perin EC, Silva GV, Assad JA et al (2008) Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol 44:486–495CrossRefPubMed
9.
go back to reference Theiss HD, David R, Engelmann MG et al (2007) Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 28:1258–1264CrossRefPubMed Theiss HD, David R, Engelmann MG et al (2007) Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 28:1258–1264CrossRefPubMed
10.
go back to reference Maehashi N, Yokota Y, Takarada A et al (1991) The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy. Analysis of 28 necropsy cases. Jpn Heart J 32:1–15PubMed Maehashi N, Yokota Y, Takarada A et al (1991) The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy. Analysis of 28 necropsy cases. Jpn Heart J 32:1–15PubMed
11.
go back to reference Suma H, Horii T, Isomura T, Buckberg G (2006) A new concept of ventricular restoration for nonischemic dilated cardiomyopathy. Eur J Cardiothorac Surg 29(Suppl 1):S207–S212CrossRefPubMed Suma H, Horii T, Isomura T, Buckberg G (2006) A new concept of ventricular restoration for nonischemic dilated cardiomyopathy. Eur J Cardiothorac Surg 29(Suppl 1):S207–S212CrossRefPubMed
12.
go back to reference Psaltis PJ, Worthley SG (2009) Endoventricular electromechanical mapping—the diagnostic and therapeutic utility of the NOGA® XP Cardiac Navigation System. J Cardiovasc Transl Res 2:48–62CrossRefPubMed Psaltis PJ, Worthley SG (2009) Endoventricular electromechanical mapping—the diagnostic and therapeutic utility of the NOGA® XP Cardiac Navigation System. J Cardiovasc Transl Res 2:48–62CrossRefPubMed
13.
go back to reference Kornowski R, Hong MK, Gepstein L et al (1998) Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 98:1116–1124PubMed Kornowski R, Hong MK, Gepstein L et al (1998) Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 98:1116–1124PubMed
14.
go back to reference Botker HE, Lassen JF, Hermansen F et al (2001) Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation 103:1631–1637PubMed Botker HE, Lassen JF, Hermansen F et al (2001) Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy. Circulation 103:1631–1637PubMed
15.
go back to reference Losordo DW, Vale PR, Hendel RC et al (2002) Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105:2012–2018CrossRefPubMed Losordo DW, Vale PR, Hendel RC et al (2002) Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105:2012–2018CrossRefPubMed
16.
go back to reference Perin EC, Dohmann HF, Borojevic R et al (2004) Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110:II213–II218CrossRefPubMed Perin EC, Dohmann HF, Borojevic R et al (2004) Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110:II213–II218CrossRefPubMed
17.
go back to reference Psaltis PJ, Carbone A, Nelson A et al (2008) An ovine model of toxic, nonischemic cardiomyopathy—assessment by cardiac magnetic resonance imaging. J Card Fail 14:785–795CrossRefPubMed Psaltis PJ, Carbone A, Nelson A et al (2008) An ovine model of toxic, nonischemic cardiomyopathy—assessment by cardiac magnetic resonance imaging. J Card Fail 14:785–795CrossRefPubMed
18.
go back to reference Gepstein L, Goldin A, Lessick J et al (1998) Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation 98:2055–2064PubMed Gepstein L, Goldin A, Lessick J et al (1998) Electromechanical characterization of chronic myocardial infarction in the canine coronary occlusion model. Circulation 98:2055–2064PubMed
19.
go back to reference Keck A, Hertting K, Schwartz Y et al (2002) Electromechanical mapping for determination of myocardial contractility and viability. A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography. J Am Coll Cardiol 40:1067–1074CrossRefPubMed Keck A, Hertting K, Schwartz Y et al (2002) Electromechanical mapping for determination of myocardial contractility and viability. A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography. J Am Coll Cardiol 40:1067–1074CrossRefPubMed
20.
go back to reference Hsia HH, Callans DJ, Marchlinski FE (2003) Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 108:704–710CrossRefPubMed Hsia HH, Callans DJ, Marchlinski FE (2003) Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation 108:704–710CrossRefPubMed
21.
go back to reference McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59CrossRefPubMed McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59CrossRefPubMed
22.
go back to reference Iles L, Pfluger H, Phrommintikul A et al (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52:1574–1580CrossRefPubMed Iles L, Pfluger H, Phrommintikul A et al (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52:1574–1580CrossRefPubMed
23.
go back to reference Bello D, Shah DJ, Farah GM et al (2003) Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108:1945–1953CrossRefPubMed Bello D, Shah DJ, Farah GM et al (2003) Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 108:1945–1953CrossRefPubMed
24.
go back to reference Nazarian S, Bluemke DA, Lardo AC et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112:2821–2825CrossRefPubMed Nazarian S, Bluemke DA, Lardo AC et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112:2821–2825CrossRefPubMed
25.
go back to reference Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60:1340–1355CrossRefPubMed Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60:1340–1355CrossRefPubMed
26.
go back to reference Waller TA, Hiser WL, Capehart JE, Roberts WC (1998) Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol 81:884–894CrossRefPubMed Waller TA, Hiser WL, Capehart JE, Roberts WC (1998) Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol 81:884–894CrossRefPubMed
27.
go back to reference de Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM (2001) Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 14:299–306CrossRefPubMed de Leeuw N, Ruiter DJ, Balk AH, de Jonge N, Melchers WJ, Galama JM (2001) Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 14:299–306CrossRefPubMed
28.
go back to reference Fuchs S, Hendel RC, Baim DS et al (2001) Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris. Am J Cardiol 87:874–880CrossRefPubMed Fuchs S, Hendel RC, Baim DS et al (2001) Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris. Am J Cardiol 87:874–880CrossRefPubMed
29.
go back to reference Poppas A, Sheehan FH, Reisman M, Harms V, Kornowski R (2004) Validation of viability assessment by electromechanical mapping by three-dimensional reconstruction with dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol 93:1097–1101CrossRefPubMed Poppas A, Sheehan FH, Reisman M, Harms V, Kornowski R (2004) Validation of viability assessment by electromechanical mapping by three-dimensional reconstruction with dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol 93:1097–1101CrossRefPubMed
30.
go back to reference Wolf T, Gepstein L, Dror U et al (2001) Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol 37:1590–1597CrossRefPubMed Wolf T, Gepstein L, Dror U et al (2001) Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol 37:1590–1597CrossRefPubMed
31.
go back to reference Fallavollita JA, Valeti U, Oza S, Canty JM Jr (2004) Spatial heterogeneity of endocardial voltage amplitude in viable, chronically dysfunctional myocardium. Basic Res Cardiol 99:212–222CrossRefPubMed Fallavollita JA, Valeti U, Oza S, Canty JM Jr (2004) Spatial heterogeneity of endocardial voltage amplitude in viable, chronically dysfunctional myocardium. Basic Res Cardiol 99:212–222CrossRefPubMed
32.
go back to reference Lessick J, Smeets JL, Reisner SA, Ben-Haim SA (2000) Electromechanical mapping of regional left ventricular function in humans: comparison with echocardiography. Catheter Cardiovasc Interv 50:10–18CrossRefPubMed Lessick J, Smeets JL, Reisner SA, Ben-Haim SA (2000) Electromechanical mapping of regional left ventricular function in humans: comparison with echocardiography. Catheter Cardiovasc Interv 50:10–18CrossRefPubMed
33.
go back to reference El Chemaly A, Guinamard R, Demion M et al (2006) A voltage-activated proton current in human cardiac fibroblasts. Biochem Biophys Res Commun 340:512–516CrossRefPubMed El Chemaly A, Guinamard R, Demion M et al (2006) A voltage-activated proton current in human cardiac fibroblasts. Biochem Biophys Res Commun 340:512–516CrossRefPubMed
Metadata
Title
Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy
Authors
Peter J. Psaltis
Angelo Carbone
Darryl P. Leong
Dennis H. Lau
Adam J. Nelson
Tim Kuchel
Troy Jantzen
Jim Manavis
Kerry Williams
Prashanthan Sanders
Stan Gronthos
Andrew C. W. Zannettino
Stephen G. Worthley
Publication date
01-01-2011
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 1/2011
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9657-5

Other articles of this Issue 1/2011

The International Journal of Cardiovascular Imaging 1/2011 Go to the issue